The effects of phospholipase A and lysolecithin on glucose 1,6-diphosphate levels and on the activities of glucose 1,6-diphosphate phosphatase, phosphofructokinase and phosphoglucomutase in the isolated rat diaphragm muscle.
D000818:Animals; D003964:Diaphragm / Q000187:drug effects / Q000201:enzymology*; D004789:Enzyme Activation; D019298:Glucose-6-Phosphate / Q000031:analogs & derivatives*; D005958:Glucosephosphates / Q000378:metabolism*; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008297:Male; D009130:Muscle, Smooth / Q000201:enzymology; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D010733:Phosphoglucomutase / Q000378:metabolism*; D010740:Phospholipases / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D051381:Rats
D005958:Glucosephosphates; D008244:Lysophosphatidylcholines; D019298:Glucose-6-Phosphate; C016473:glucose-1,6-bisphosphate; D010732:Phosphofructokinase-1; D010740:Phospholipases; D010741:Phospholipases A; C014818:glucose 1,6-diphosphate phosphatase; D010744:Phosphoric Monoester Hydrolases; D010733:Phosphoglucomutase